Global Postmenopausal Osteoporosis Therapeutics Market Research Report 2023

Report ID: 1992299 | Published Date: Oct 2024 | No. of Page: 80 | Base Year: 2023 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Postmenopausal Osteoporosis Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Bisphosphonates
        1.2.3 Hormones
        1.2.4 Strontium Ranelate
        1.2.5 Raloxifene
        1.2.6 Denosumab
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Postmenopausal Osteoporosis Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospital Pharmacies
        1.3.3 Online Pharmacies
        1.3.4 Retail Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Postmenopausal Osteoporosis Therapeutics Market Perspective (2018-2029)
    2.2 Postmenopausal Osteoporosis Therapeutics Growth Trends by Region
        2.2.1 Global Postmenopausal Osteoporosis Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Postmenopausal Osteoporosis Therapeutics Historic Market Size by Region (2018-2023)
        2.2.3 Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Region (2024-2029)
    2.3 Postmenopausal Osteoporosis Therapeutics Market Dynamics
        2.3.1 Postmenopausal Osteoporosis Therapeutics Industry Trends
        2.3.2 Postmenopausal Osteoporosis Therapeutics Market Drivers
        2.3.3 Postmenopausal Osteoporosis Therapeutics Market Challenges
        2.3.4 Postmenopausal Osteoporosis Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Postmenopausal Osteoporosis Therapeutics Players by Revenue
        3.1.1 Global Top Postmenopausal Osteoporosis Therapeutics Players by Revenue (2018-2023)
        3.1.2 Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Players (2018-2023)
    3.2 Global Postmenopausal Osteoporosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Postmenopausal Osteoporosis Therapeutics Revenue
    3.4 Global Postmenopausal Osteoporosis Therapeutics Market Concentration Ratio
        3.4.1 Global Postmenopausal Osteoporosis Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Postmenopausal Osteoporosis Therapeutics Revenue in 2022
    3.5 Postmenopausal Osteoporosis Therapeutics Key Players Head office and Area Served
    3.6 Key Players Postmenopausal Osteoporosis Therapeutics Product Solution and Service
    3.7 Date of Enter into Postmenopausal Osteoporosis Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Postmenopausal Osteoporosis Therapeutics Breakdown Data by Type
    4.1 Global Postmenopausal Osteoporosis Therapeutics Historic Market Size by Type (2018-2023)
    4.2 Global Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Type (2024-2029)
5 Postmenopausal Osteoporosis Therapeutics Breakdown Data by Application
    5.1 Global Postmenopausal Osteoporosis Therapeutics Historic Market Size by Application (2018-2023)
    5.2 Global Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Postmenopausal Osteoporosis Therapeutics Market Size (2018-2029)
    6.2 North America Postmenopausal Osteoporosis Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2018-2023)
    6.4 North America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Postmenopausal Osteoporosis Therapeutics Market Size (2018-2029)
    7.2 Europe Postmenopausal Osteoporosis Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Postmenopausal Osteoporosis Therapeutics Market Size by Country (2018-2023)
    7.4 Europe Postmenopausal Osteoporosis Therapeutics Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size (2018-2029)
    8.2 Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Region (2018-2023)
    8.4 Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Postmenopausal Osteoporosis Therapeutics Market Size (2018-2029)
    9.2 Latin America Postmenopausal Osteoporosis Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2018-2023)
    9.4 Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size (2018-2029)
    10.2 Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Country (2018-2023)
    10.4 Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Eli Lilly
        11.1.1 Eli Lilly Company Detail
        11.1.2 Eli Lilly Business Overview
        11.1.3 Eli Lilly Postmenopausal Osteoporosis Therapeutics Introduction
        11.1.4 Eli Lilly Revenue in Postmenopausal Osteoporosis Therapeutics Business (2018-2023)
        11.1.5 Eli Lilly Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Detail
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Postmenopausal Osteoporosis Therapeutics Introduction
        11.2.4 Pfizer Revenue in Postmenopausal Osteoporosis Therapeutics Business (2018-2023)
        11.2.5 Pfizer Recent Development
    11.3 F. Hoffman La Roche
        11.3.1 F. Hoffman La Roche Company Detail
        11.3.2 F. Hoffman La Roche Business Overview
        11.3.3 F. Hoffman La Roche Postmenopausal Osteoporosis Therapeutics Introduction
        11.3.4 F. Hoffman La Roche Revenue in Postmenopausal Osteoporosis Therapeutics Business (2018-2023)
        11.3.5 F. Hoffman La Roche Recent Development
    11.4 Procter & Gamble
        11.4.1 Procter & Gamble Company Detail
        11.4.2 Procter & Gamble Business Overview
        11.4.3 Procter & Gamble Postmenopausal Osteoporosis Therapeutics Introduction
        11.4.4 Procter & Gamble Revenue in Postmenopausal Osteoporosis Therapeutics Business (2018-2023)
        11.4.5 Procter & Gamble Recent Development
    11.5 Merck
        11.5.1 Merck Company Detail
        11.5.2 Merck Business Overview
        11.5.3 Merck Postmenopausal Osteoporosis Therapeutics Introduction
        11.5.4 Merck Revenue in Postmenopausal Osteoporosis Therapeutics Business (2018-2023)
        11.5.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Postmenopausal Osteoporosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Bisphosphonates
    Table 3. Key Players of Hormones
    Table 4. Key Players of Strontium Ranelate
    Table 5. Key Players of Raloxifene
    Table 6. Key Players of Denosumab
    Table 7. Key Players of Others
    Table 8. Global Postmenopausal Osteoporosis Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Postmenopausal Osteoporosis Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 10. Global Postmenopausal Osteoporosis Therapeutics Market Size by Region (2018-2023) & (US$ Million)
    Table 11. Global Postmenopausal Osteoporosis Therapeutics Market Share by Region (2018-2023)
    Table 12. Global Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 13. Global Postmenopausal Osteoporosis Therapeutics Market Share by Region (2024-2029)
    Table 14. Postmenopausal Osteoporosis Therapeutics Market Trends
    Table 15. Postmenopausal Osteoporosis Therapeutics Market Drivers
    Table 16. Postmenopausal Osteoporosis Therapeutics Market Challenges
    Table 17. Postmenopausal Osteoporosis Therapeutics Market Restraints
    Table 18. Global Postmenopausal Osteoporosis Therapeutics Revenue by Players (2018-2023) & (US$ Million)
    Table 19. Global Postmenopausal Osteoporosis Therapeutics Market Share by Players (2018-2023)
    Table 20. Global Top Postmenopausal Osteoporosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postmenopausal Osteoporosis Therapeutics as of 2022)
    Table 21. Ranking of Global Top Postmenopausal Osteoporosis Therapeutics Companies by Revenue (US$ Million) in 2022
    Table 22. Global 5 Largest Players Market Share by Postmenopausal Osteoporosis Therapeutics Revenue (CR5 and HHI) & (2018-2023)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Postmenopausal Osteoporosis Therapeutics Product Solution and Service
    Table 25. Date of Enter into Postmenopausal Osteoporosis Therapeutics Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Postmenopausal Osteoporosis Therapeutics Market Size by Type (2018-2023) & (US$ Million)
    Table 28. Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Type (2018-2023)
    Table 29. Global Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 30. Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Type (2024-2029)
    Table 31. Global Postmenopausal Osteoporosis Therapeutics Market Size by Application (2018-2023) & (US$ Million)
    Table 32. Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Application (2018-2023)
    Table 33. Global Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 34. Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Application (2024-2029)
    Table 35. North America Postmenopausal Osteoporosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. North America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 37. North America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Europe Postmenopausal Osteoporosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Europe Postmenopausal Osteoporosis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 40. Europe Postmenopausal Osteoporosis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 41. Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Region (2018-2023) & (US$ Million)
    Table 43. Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Region (2024-2029) & (US$ Million)
    Table 44. Latin America Postmenopausal Osteoporosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 48. Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 50. Eli Lilly Company Detail
    Table 51. Eli Lilly Business Overview
    Table 52. Eli Lilly Postmenopausal Osteoporosis Therapeutics Product
    Table 53. Eli Lilly Revenue in Postmenopausal Osteoporosis Therapeutics Business (2018-2023) & (US$ Million)
    Table 54. Eli Lilly Recent Development
    Table 55. Pfizer Company Detail
    Table 56. Pfizer Business Overview
    Table 57. Pfizer Postmenopausal Osteoporosis Therapeutics Product
    Table 58. Pfizer Revenue in Postmenopausal Osteoporosis Therapeutics Business (2018-2023) & (US$ Million)
    Table 59. Pfizer Recent Development
    Table 60. F. Hoffman La Roche Company Detail
    Table 61. F. Hoffman La Roche Business Overview
    Table 62. F. Hoffman La Roche Postmenopausal Osteoporosis Therapeutics Product
    Table 63. F. Hoffman La Roche Revenue in Postmenopausal Osteoporosis Therapeutics Business (2018-2023) & (US$ Million)
    Table 64. F. Hoffman La Roche Recent Development
    Table 65. Procter & Gamble Company Detail
    Table 66. Procter & Gamble Business Overview
    Table 67. Procter & Gamble Postmenopausal Osteoporosis Therapeutics Product
    Table 68. Procter & Gamble Revenue in Postmenopausal Osteoporosis Therapeutics Business (2018-2023) & (US$ Million)
    Table 69. Procter & Gamble Recent Development
    Table 70. Merck Company Detail
    Table 71. Merck Business Overview
    Table 72. Merck Postmenopausal Osteoporosis Therapeutics Product
    Table 73. Merck Revenue in Postmenopausal Osteoporosis Therapeutics Business (2018-2023) & (US$ Million)
    Table 74. Merck Recent Development
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Postmenopausal Osteoporosis Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Postmenopausal Osteoporosis Therapeutics Market Share by Type: 2022 VS 2029
    Figure 3. Bisphosphonates Features
    Figure 4. Hormones Features
    Figure 5. Strontium Ranelate Features
    Figure 6. Raloxifene Features
    Figure 7. Denosumab Features
    Figure 8. Others Features
    Figure 9. Global Postmenopausal Osteoporosis Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 10. Global Postmenopausal Osteoporosis Therapeutics Market Share by Application: 2022 VS 2029
    Figure 11. Hospital Pharmacies Case Studies
    Figure 12. Online Pharmacies Case Studies
    Figure 13. Retail Pharmacies Case Studies
    Figure 14. Postmenopausal Osteoporosis Therapeutics Report Years Considered
    Figure 15. Global Postmenopausal Osteoporosis Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 16. Global Postmenopausal Osteoporosis Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 17. Global Postmenopausal Osteoporosis Therapeutics Market Share by Region: 2022 VS 2029
    Figure 18. Global Postmenopausal Osteoporosis Therapeutics Market Share by Players in 2022
    Figure 19. Global Top Postmenopausal Osteoporosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postmenopausal Osteoporosis Therapeutics as of 2022)
    Figure 20. The Top 10 and 5 Players Market Share by Postmenopausal Osteoporosis Therapeutics Revenue in 2022
    Figure 21. North America Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. North America Postmenopausal Osteoporosis Therapeutics Market Share by Country (2018-2029)
    Figure 23. United States Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Canada Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Europe Postmenopausal Osteoporosis Therapeutics Market Share by Country (2018-2029)
    Figure 27. Germany Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. France Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. U.K. Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Italy Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Russia Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Nordic Countries Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Share by Region (2018-2029)
    Figure 35. China Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Japan Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. South Korea Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Southeast Asia Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. India Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Australia Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Latin America Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Latin America Postmenopausal Osteoporosis Therapeutics Market Share by Country (2018-2029)
    Figure 43. Mexico Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Brazil Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Share by Country (2018-2029)
    Figure 47. Turkey Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Saudi Arabia Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 49. Eli Lilly Revenue Growth Rate in Postmenopausal Osteoporosis Therapeutics Business (2018-2023)
    Figure 50. Pfizer Revenue Growth Rate in Postmenopausal Osteoporosis Therapeutics Business (2018-2023)
    Figure 51. F. Hoffman La Roche Revenue Growth Rate in Postmenopausal Osteoporosis Therapeutics Business (2018-2023)
    Figure 52. Procter & Gamble Revenue Growth Rate in Postmenopausal Osteoporosis Therapeutics Business (2018-2023)
    Figure 53. Merck Revenue Growth Rate in Postmenopausal Osteoporosis Therapeutics Business (2018-2023)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly
Pfizer
F. Hoffman La Roche
Procter & Gamble
Merck
Frequently Asked Questions
Postmenopausal Osteoporosis Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Postmenopausal Osteoporosis Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Postmenopausal Osteoporosis Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Potassium Sorbate

This report aims to provide a comprehensive presentation of the global market for Potassium Sorba ... Read More